Search results
Pharm Exec Exclusive: Mark Cuban Talks Drug Pricing
Pharmaceutical Executive Magazine· 20 hours agoCuban’s direct-to-consumer (DTC) Cost Plus Drug Company, which does business as Cost Plus ...
Pharma Stock Roundup: LLY's CFO Departs, ABBV, AZN Drugs Get CHMP Approval
Zacks via Yahoo Finance· 2 hours agoPrezcobix/Rezolsta is a two-drug fixed-dose combination tablet for treating HIV-1 infection in...
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 5 hours agoHemgenix gained U.S. approval in late 2022 and also costs $3.5 million before insurance deductions...
My 2 Favorite Stocks to Buy Right Now
Motley Fool via Yahoo Finance· 6 hours agoThe debt-to-equity ratio is around 0.5 and it covers its trailing interest expenses by a robust 26 times. There's no imminent financial risk here. Plus,...
Oscar Health CEO Mark Bertolini is ready to take on the employer market
CNBC· 3 hours agoMark Bertolini has helped Oscar Health move toward profitability after taking over as CEO of the...
5 Stocks in Focus as Alcohol Industry Faces Inflation Wrath
Zacks via Yahoo Finance· 3 hours agoThe Beverages - Alcohol industry continues to be in the doldrums, thanks to commodity cost inflation...
Rx drug shortages hit all-time high, affecting prices
FOX 59 Indianapolis· 3 days agoINDIANAPOLIS – Across the nation, consumers are dealing with the effects of prescription drug...
A crisis is hitting your local drugstore. Why the slow demise of a 130-year-old family-owned...
Fortune via Yahoo Finance· 4 days agoSeattle's beloved Bartell’s, now owned by debt-laden Rite Aid, is closing many of its locations....
JD Supra: Better Health Care Newsletter
JD Supra· 1 day agoFederal officials have capped the cost of insulin at $35 a month. For now, that gives relief only to patients 65 and older covered by Medicare. Big Pharma in recent years has flouted that charitable intent.
CG Oncology reports promising bladder cancer trial results By Investing.com
Investing.com· 23 hours agoCG Oncology, Inc. (NASDAQ: CGON), a biopharmaceutical company engaged in the development of oncology...
